Rainier Group Investment Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$573K Buy
2,255
+243
+12% +$60.2K 0.23% 27
2020
Q2
$475K Sell
2,012
-38
-2% -$8.67K 0.21% 23
2020
Q1
$416K Buy
2,050
+146
+8% +$31.9K 2.71% 7
2019
Q4
$459K Sell
1,904
-384
-17% -$84.6K 0.19% 24
2019
Q3
$443K Buy
2,288
+69
+3% +$13.2K 0.2% 23
2019
Q2
$409K Buy
2,219
+89
+4% +$15.9K 0.18% 27
2019
Q1
$405K Buy
2,130
+135
+7% +$25.8K 0.18% 24
2018
Q4
$388K Buy
1,995
+173
+9% +$33.8K 0.18% 22
2018
Q3
$378K Buy
1,822
+20
+1% +$3.94K 0.15% 25
2018
Q2
$333K Sell
1,802
-2,236
-55% -$396K 0.14% 26
2018
Q1
$688K Buy
4,038
+1,097
+37% +$201K 0.31% 19
2017
Q4
$511K Sell
2,941
-200
-6% -$35.4K 0.26% 21
2017
Q3
$586K Hold
3,141
0.31% 15
2017
Q2
$541K Sell
3,141
-257
-8% -$41.8K 0.31% 18
2017
Q1
$558K Buy
3,398
+157
+5% +$26.1K 0.26% 20
2016
Q4
$474K Buy
+3,241
New +$488K 0.22% 24

Other funds holding AMGN

Rainier Group Investment Advisory's AMGN Position: Q3 2020 in Review

Rainier Group Investment Advisory increased its Amgen (AMGN) stake by 12% in Q3 2020, buying an estimated $60.2K and bringing the position to 2,255 shares worth $573K. The position accounts for 0.23% of the portfolio, ranked #27.

Rainier Group Investment Advisory first reported a position in AMGN in Q4 2016 and has held it in 16 quarters since. The position peaked at $688K in Q1 2018. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Rainier Group Investment Advisory held 2,255 shares of Amgen worth $573K as of Q3 2020.
  • Rainier Group Investment Advisory bought 243 Amgen shares in Q3 2020, an estimated $60.2K.
  • Amgen made up 0.23% of Rainier Group Investment Advisory's portfolio in Q3 2020, its #27 holding.
  • Rainier Group Investment Advisory first reported a position in Amgen in Q4 2016 and has held it in 16 quarters since.
  • Rainier Group Investment Advisory's Amgen position peaked at $688K in Q1 2018.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Rainier Group Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.